Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Olympus
AddedFeb 15, 2024
UpdatedJun 28, 2026
Olympus

Olympus

Public

Japanese-based Olympus, a leading global manufacturer of optics and reprography products, dominates the endoscope market.

HQ
Tokyo, Tokyo, JP
Founded
1919
Overview
Compare
Fundraising
Employees
Website

Olympus, a Japanese-based company founded on October 12, 1919, specializes in optics and reprography products. Initially focusing on microscopes and thermometers, Olympus has evolved to become a dominant player in the medical technology sector, particularly in endoscopes. The company holds approximately a 70 percent share of the global endoscope market, valued at around US$2.5 billion. Its global headquarters are located in Shinjuku, Tokyo, Japan.

Olympus has made significant contributions to medical technology, enhancing diagnostic and surgical procedures worldwide. The company's innovations in endoscopy have improved patient outcomes and set industry standards. With a century-long legacy of excellence, Olympus continues to impact the healthcare sector profoundly, supported by a strong reputation for quality and reliability.

Olympus - Similar Companies

Olympus Americas logo

Olympus Americas

olympus.com

Nikon logo

Nikon

nikon.com

Pentax Medical logo

Pentax Medical

Konica Minolta logo

Konica Minolta

konicaminolta.com

Fujifilm logo

Fujifilm

fujifilm.com

Hoya logo

Hoya

Zeiss logo

Zeiss

zeiss.com

Omron logo

Omron

Canon logo

Canon

Terumo logo

Terumo

Bausch & Lomb logo

Bausch & Lomb

bausch.com

Carl Zeiss Meditec logo

Carl Zeiss Meditec

Optikos logo

Optikos

optikos.com

Hamamatsu Photonics logo

Hamamatsu Photonics

hamamatsu.com

Olive Medical logo

Olive Medical

Olympus - Quick Facts

Who are Olympus' competitors?

Companies similar to Olympus include Olympus Americas, Nikon, Pentax Medical and Konica Minolta.

When was Olympus founded?

Olympus was founded in 1919.

Where is Olympus' headquarters located?

Olympus' headquarters is located in Tokyo, Tokyo, JP.

When was Olympus' last funding round?

Olympus' most recent funding round was for $600M (USD) in May 2018.

How much has Olympus raised to-date?

As of May 31, 2018, Olympus has raised a total of $600M (USD).

How many employees does Olympus have?

Olympus has 31,557 employees as of Feb 6, 2024.

Olympus - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Optics
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Cameras
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 333300Commercial and Service Industry Machinery Manufacturing
  • 333310Commercial and Service Industry Machinery Manufacturing
  • 330000Manufacturing
  • 333000Machinery Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3827Optical Instruments And Lenses
ISIC
  • 4649Wholesale of other household goods
  • 4659Wholesale of other machinery and equipment
  • 4773Other retail sale of new goods in specialized stores
Show 10 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 335000Electrical Equipment, Appliance, and Component Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies